Guides

Coronary Heart Disease and HIV: Risk, Prevention, and Treatment

Coronary heart disease and HIV
Guides

Coronary Heart Disease and HIV: Risk, Prevention, and Treatment

References UK clinical guidance from the NHS, the British HIV Association (BHIVA), and the British Association for Sexual Health and HIV (BASHH). Last updated: April 2026.

People living with HIV have approximately a 1.5-2 times higher risk of coronary heart disease compared to the general population. This elevated risk is driven by chronic inflammation from HIV, side effects of some antiretroviral drugs, higher rates of traditional risk factors, and accelerated aging of blood vessels.

Managing cardiovascular risk is an important part of long-term health with HIV. Most cardiovascular events are preventable with the right approach.

Why HIV Increases Heart Disease Risk

Chronic inflammation

Even well-controlled HIV on effective ART leaves persistent low-level inflammation in the body. This inflammation damages blood vessel walls, promotes atherosclerosis (plaque buildup), and increases the risk of blood clots.

ART side effects

Some antiretroviral drugs affect cardiovascular risk:

  • Protease inhibitors (particularly older ones) can raise cholesterol and promote insulin resistance
  • Abacavir has been associated with a small increase in cardiovascular events in some studies (debated)
  • Weight gain from integrase inhibitors and TAF can contribute to cardiovascular risk

Traditional risk factors

People with HIV have higher rates of:

  • Smoking
  • High cholesterol
  • Insulin resistance and diabetes
  • High blood pressure
  • Recreational drug use

How to Protect Your Heart

ActionImpact
Stay on effective ARTReduces HIV-related inflammation
Stop smokingSingle biggest impact on cardiovascular risk
Control cholesterolConsider statins if elevated
Control blood pressureTarget below 140/90 (or lower with diabetes)
Exercise regularly150 minutes moderate activity per week
Healthy dietMediterranean-style diet reduces risk
Manage diabetesIf present, tight glucose control
Maintain healthy weightParticularly important with modern ART
Limit alcoholNo more than 14 units per week

Statins and HIV

Statins are effective for cardiovascular risk reduction but interact with some ART drugs. Important considerations:

  • Simvastatin: Contraindicated with protease inhibitors and cobicistat
  • Atorvastatin: Can be used with caution (dose reduction)
  • Pitavastatin and pravastatin: Few interactions, often preferred for HIV patients

Your HIV specialist and GP will coordinate the safest choice.

Read more: HIV and cholesterol | HIV and stroke | What is HIV?

Frequently Asked Questions

Will my HIV treatment cause a heart attack?

Modern HIV treatment is much safer for cardiovascular health than older drugs. The overall benefit of effective ART (reducing inflammation, improving health) outweighs cardiovascular risks from specific drugs. Older protease inhibitors had more impact, but newer regimens are cardiovascular-friendly.

At what age should I worry about heart disease with HIV?

Cardiovascular events tend to occur 5-10 years earlier in people with HIV. Risk assessment and preventive measures should start earlier than for the general population. Discuss with your HIV specialist from around age 35-40.

Sources

Have questions? Get tested from home.

Confidential, accurate, and rapid results you can trust.

Order a Test Kit